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ORIGINAL ARTICLE
Measuring maternal near-miss in a middle-income country: assessing the use
of WHO and sub-Saharan Africa maternal near-miss criteria in Namibia
Steffie Heemelaar a,b, Leonard Kabongoc, Taati Ithindid, Christian Luboyae, Fidelis Munetsif,
Ann-Kathrin Bauerg, Amelie Dammanng, Anna Drewesg, Jelle Stekelenburg g,h, Thomas van den Akkerb
and Shonag Mackenzie i
aDepartment of Obstetrics and Gynaecology, Katutura State Hospital, Windhoek, Namibia; bDepartment of Obstetrics, Leiden University
Medical Center, Leiden, The Netherlands; cDepartment of Obstetrics and Gynaecology, Gobabis State Hospital, Gobabis, Namibia;
dNational Maternal Death, Stillbirth and Neonatal Death Review Committee, Ministry of Health and Social Services, Windhoek, Namibia;
eDepartment of Obstetrics and Gynaecology, Rundu Intermediate Hospital, Rundu, Namibia; fDepartment of Obstetrics and
Gynaecology, Okahandja State Hospital, Okahandja, Namibia; gDepartment of Health Science, Global Health, University of Groningen/
University Medical Centre Groningen, Groningen, The Netherlands; hDepartment of Obstetrics and Gynaecology, Medical Center
Leeuwarden, Leeuwarden, The Netherlands; iDepartment of Obstetrics and Gynaecology, University of Namibia, Windhoek, Namibia
ABSTRACT
Background: Namibia, a middle-income country in sub-Saharan Africa (SSA), plans to use the
Maternal Near Miss (MNM) approach. Adaptations of the World Health Organization (WHO)
MNM defining criteria (‘WHO MNM criteria’) were previously proposed for low-income set-
tings in sub-Saharan Africa (‘SSA MNM criteria’), but whether these adaptations are required
in middle-income settings is unknown.
Objective: To establish MNM criteria suitable for use in Namibia, a middle-income country in
SSA.
Methods: Cross-sectional study from 1 March 2018 to 31 May 2018 in four Namibian
hospitals. Pregnant women or within 42 days of termination of pregnancy or birth, fulfilling
at least one WHO or SSA MNM criterion were included. Records of women identified by either
only WHO criteria or only SSA criteria were assessed in detail.
Results: 194 Women fulfilled any MNM criterion. WHO criteria identified 61 MNM, the SSA
criteria 184 MNM. Of women who only fulfilled any of the unique SSA MNM criteria, 18
fulfilled the criterion ‘eclampsia’, one ‘uterine rupture’ and five ‘laparotomy’. These women
were assessed to be MNM. Thresholds for blood transfusion to define MNM due to haemor-
rhage were two units in the SSA and five in WHO set. Two or three units were given to 95
women for mild/moderate haemorrhage or chronic anaemia who did not fulfil any WHO
criterion and were not considered MNM. Fourteen women who were assessed to be MNM
from severe haemorrhage received four units.
Conclusions: WHO MNM criteria may underestimate and SSA MNM criteria overestimate the
prevalence of MNM in a middle-income country such as Namibia, where MNM criteria ‘in
between’ may be more appropriate. Namibia opts to apply a modification of the WHO criteria,
including eclampsia, uterine rupture, laparotomy and a lower threshold of four units of blood
to define MNM. We recommend that other middle-income countries validate our criteria for
their setting.
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Maternal mortality has been reduced but remains
high in sub-Saharan Africa (SSA) [1]. Even though
sub-Saharan African countries aim for zero avoidable
maternal deaths, many struggle to achieve substantial
progress [1–5]. To further improve quality of mater-
nity care, the World Health Organization (WHO) has
promoted the Maternal Near-Miss (MNM) approach
since 2004 [6]. An MNM is ‘a woman who nearly
died but survived a pregnancy-related complication
during pregnancy, birth or within 42 days after ter-
mination or delivery’ [6]. Women with an MNM
event often share the same characteristics and risk
factors as women who died, such as underlying med-
ical or pregnancy-related conditions and delays in
reaching and obtaining adequate health care. Much
can be learned with regard to the functioning of the
health system, and failing of the system, by analysing
MNM and maternal deaths. However, MNM occurs
in larger numbers and may be less threatening for
health-care workers to discuss since these can be
regarded as great saves [7,8].
Namibia has a high maternal mortality ratio of an
estimated 385/100,000 livebirths in 2013 [9]. Even
though it has a very large surface area, it is one of
the least densely populated countries in the world
with 2.8 people per square kilometer [10]. Annually,
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there are around 75,000 births [10]. To analyse and
improve maternity care, Namibia is planning to apply
the MNM approach. Adoption of a recognized set of
MNM criteria will allow comparison across settings
and is therefore preferred. Reports from other SSA
countries indicated that the WHO MNM criteria
(Appendix 1) may not be suitable for use in district
hospitals in low-income settings, due to limited avail-
ability of laboratory tests, blood products and man-
agement options leading to under-registration of
MNM [11,12]. Recently, a Delphi study was pub-
lished proposing MNM criteria deemed suitable for
hospitals in low-income settings in SSA [13]. The SSA
criteria added several clinical criteria such as eclamp-
sia, sepsis and uterine rupture and lowered the
threshold for blood transfusion from five to two
units of red cells (Appendix 1). For Namibia, classi-
fied by the World Bank as a sub-Saharan upper
middle-income country, it is unclear which set of
MNM criteria would be appropriate to use [14]. The
national referral hospital in Windhoek, the capital of
Namibia, has all the facilities to apply the WHO
MNM criteria, but in district hospitals, several labora-
tory tests to identify organ failure or management
options are not available. Nevertheless, Namibian
district hospitals are generally better supplied com-
pared to most district hospitals in low-income set-
tings in SSA. The aim of this study was to establish
MNM criteria suitable for use in all Namibian hospi-
tals by applying both the WHO and the adapted SSA
MNM criteria to a cohort of women in four
Namibian hospitals.
Methods
Study setting and design
Participating facilities were the national referral hos-
pital, Windhoek Hospital Complex (Hospital A),
a large regional hospital, Rundu Intermediate
Hospital (Hospital B), and two smaller district hospi-
tals, Gobabis and Okahandja State Hospital (Hospital
C and D). The hospitals were selected based on their
characteristics, to obtain a representative sample of
Namibian hospitals. Namibia has only three regional
hospitals of which one is part of the hospital complex
in the capital (Hospital A). Hospital B and the third
regional hospital (not included) are similar in terms
of number of births, available resources and catch-
ment area. Of the 31 district hospitals, approximately
half have more than 2000 births annually. Staff and
resources are allocated accordingly. We selected two
district hospitals representing a higher and lower-
burden facility. Since Namibia is a large but sparsely
populated country with long distances between
health-care facilities, Hospital C was chosen since
this facility is located in one of the least densely
populated districts.
Hospital A is located in the capital, has almost
14,000 births annually, and is the only tertiary facility
in Namibia for the entire population of 2.3 million
[10]. There are three consultant obstetrician and
gynaecologists. The Intensive Care Unit (ICU) has
advanced equipment including ventilators and
a dialysis machine. Sophisticated laboratory tests
including pH and lactate measurements are available
to identify and manage organ failure. Hospital B is
located near the Angolan border, has just over 6,000
births annually and serves a population of approxi-
mately 350,000 [10]. There is one consultant gynae-
cologist, an ICU with mechanical ventilation and
a well-supplied blood bank. The district hospitals
have around 2500 and 1200 births, respectively, and
there are no ICU facilities or consultants. Hospital
C has basic haematology and chemistry laboratory
tests available on site. Hospital D has no laboratory
tests on site. Both district hospitals have a reliable
supply of red cells for blood transfusion but no other
blood products.
For this prospective cross-sectional study we
included all pregnant women or within 42 days
after termination of pregnancy or birth, regardless
of gestational age, fulfilling at least one WHO or
SSA MNM criterion. Furthermore, they had to pre-
sent between 1 March 2018 and 31st of May 2018 to
the participating facilities [6,13]. Maternal deaths,
defined as death of a woman while pregnant or
within 42 days of termination of pregnancy or birth,
from any cause related to or aggravated by the preg-
nancy or its management, but not from accidental or
incidental causes, were excluded [6].
MNM identification criteria and sample size
The WHO and SSA criteria are presented in Appendix
1. The SSA criterion ‘Laparotomy other than caesarean
section’ was modified to ‘Laparotomy other than cae-
sarean section (CS) or ectopic pregnancy’, since we
anticipated an over-reporting of ectopic pregnancies
that were not necessarily an MNM. The threshold of
transfusion of two units of blood was adopted from the
SSAMNM criteria. TheWHOMNM criterion defining
MNM from haemorrhage has a threshold of five units
of blood, so inclusion from two units of blood and
above would allow further analysis of the women who
received two, three or four units of blood to identify
which threshold would most accurately define severe
haemorrhage without over-reporting mild or moderate
haemorrhage. In the proposed SSA criterion ‘severe
pre-eclampsia with ICU admission’, ICU was not
clearly defined. For our study, we decided to regard
the ICU as a ward where mechanical ventilation and
administration of continuous vasoactive drugs were
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possible, together with the continuous presence of
a medical doctor.
At the time of design of the study, the performance
of the SSA criteria was not yet assessed in clinical
setting, rendering sample size calculations difficult.
A large global study performed by the WHO found
a prevalence of approximately 15 MNM per 1000 live
births in countries with a maternal mortality ratio
similar to that of Namibia [6,15]. Considering the
lower threshold for transfusion and the addition of
clinical criteria, we expected the SSA criteria to iden-
tify approximately twice as many MNM. To identify
at least five MNM in the district hospitals, we set our
study period at 3 months, with the possibility to
extend it with another 3 months in case of insuffi-
cient inclusions in hospital C and D.
Data collection and analysis
Doctors and nurses working in participating facilities,
involved in the care of pregnant and/or postpartum
women were trained in MNM identification and data
collection prior to the study by members of the
research team. A manual with information on data
collection was present in each participating facility.
MNM identification and data collection were sup-
ported in hospital A through daily visits to the mater-
nity wards, gynaecology wards, acute care and ICU by
AB, AD, AD, SH. On the respective wards, the admis-
sion books were screened for possible missed MNM.
The register of the blood bank was screened for
missed MNM by screening blood units delivered to
the above-mentioned wards. Daily rounds and
screening of blood bank registers were not feasible
in the other hospitals due to budget and logistical
restrictions. In hospitals B, C and D a doctor and
two nurses were in charge of the project. These staff
members were supervising MNM identification and
data collection and were in close contact with the
research team for support.
For the identified MNM, data were collected anon-
ymously from medical records using a structured data
collection tool, including socio-demographic charac-
teristics, contributing factors, maternal and neonatal
outcome, the main cause of MNM and long-term
complications. All collected data were verified with
medical records by either SH, LK, CL, FM, SM, who
are medical doctors with at least 3 years of experience
providing obstetric care in Namibia. We collected the
total number of live births and maternal deaths that
occurred within the facility during the study period.
Data were double entered and crosschecked in
Epidata version 4.2. Data analysis consisted of fre-
quencies of demographic and clinical variables. Data
analysis was performed with SPSS version 22. All
results are reported as numbers (n) and frequencies.
Confidence intervals (CI) were calculated using the
Clopper-Pearson exact test.
Severe maternal outcome (SMO) was defined as
the number of MNM and maternal deaths combined.
The MNM ratio was defined as the number of mater-
nal near-miss per 1000 live births and the SMO ratio
by the number of women with SMO per 1000 live
births [6]. The confidence interval was calculated
using Poisson distribution.
In order to establish MNM criteria which will
identify all MNM in Namibian hospitals without
over-reporting minor morbidities we did the follow-
ing: for the women identified as an MNM by one of
the unique criteria, medical records were reviewed by
SH, LK, CL, FM, SM. Based on their clinical judge-
ment it was decided for each unique criterion if it
should be used for MNM identification in Namibia.
This study was reviewed and approved by the
research unit of the Namibian Ministry of Health
and Social Services. We followed the STROBE report-
ing guidelines.
Results
In the three-month study period, 194 women were
identified to be MNM according to the WHO and/or
SSA criteria. Of these 194 MNM, 31 were identified
through the blood bank register and ward registers of
hospital A. Nine women were included by staff, but
upon verification with medical records, it appeared
these did not fulfil any MNM criterion and were
excluded. Four of these nine women were included
for ‘severe pre-eclampsia with ICU admission’, how-
ever these women were not admitted to an ICU
department. Two women received one unit of blood
for transfusion, whereas the threshold of the MNM
criterion was at least two units of blood. Two women
were included for sepsis but did not reach any of the
clinical thresholds in the definition of the SSA criter-
ion, Appendix 1. One woman was included for uterine
rupture. However, only a pending uterine rupture was
found with the lower uterine segment thin but intact.
Characteristics of the identified MNM are pre-
sented in Table 1. There were 32 (16.5%) teenage
pregnancies and 60 (30.9%) women were primipar-
ous. Chronic anaemia was present in 32 (16.5%)
women. Obstructed labour was present in 18 (9.3%)
women and 71 (36.6%) women gave birth by caesar-
ean section. Miscarriage was present in 31 women, of
whom 28 needed surgical evacuation, one women
received medical treatment and two women had
a spontaneous complete abortion.
Table 2 shows the number of live births, MNM,
MD, MNM ratio and SMO ratio for each hospital.
Hospital A had the most live births (3515) in the
three-month study period, most MNM (150) and the
highest MNM ratio (43/1000 live births). The six
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maternal deaths in hospital A were due to tuberculosis
(2), hepatitis E (2), ruptured uterus (1) and septic
miscarriage (1). The three maternal deaths in hospital
B were due to complicated malaria (2) and a woman
who died upon arrival due to an unclear cause. The
SMO ratio for all hospitals was 35/1000 live births,
95% CI 30–40.
Underlying causes of MNM and MNM criteria
The underlying cause of the MNM is presented in
Figure 1. The commonest causeswere obstetric haemor-
rhage (75, 38.7%, 95% CI 31.8–45.9), abortion-related
complications (44, 22.7%, 95%CI 17.0–29.2) and hyper-
tensive disorders (36, 18.6%, 95% CI 13.3–24.8).
Table 3 compares the two sets of MNM criteria
and the frequency of each criterion present among
the 194 MNM. The frequencies of each criterion
separated for the four hospitals are presented in
Appendix 2. Of the unique SSA criteria, eclampsia
and sepsis were most frequently present with 26
women fulfilling each of these criteria. Eighteen
women with eclampsia and 16 women with sepsis
did not fulfil any WHO criterion and would have
been missed by this set of criteria. Sepsis was caused
by endometritis (6), septic miscarriage (3), pyelone-
phritis (2), wound sepsis (2), abdominal sepsis (2)
and pneumonia (1). For these women, sepsis resolved
within 24 h after starting antibiotics, wound treat-
ment or evacuation of retained products of concep-
tion and therefore were assessed as not severe
morbidity. There were two women with uterine rup-
ture of whom one did not fulfil any other WHO
criterion. All women with eclampsia and uterine
rupture were assessed as severe morbidity. Four
women with severe malaria had also either renal,
hepatic or neurological dysfunction and this criterion
did not contribute to the identification of MNM. The
five women who fulfilled the criterion of ‘laparotomy
other than caesarean section or ectopic pregnancy’
but no other (WHO) criteria were due to septic
cervical ectopic pregnancy not suitable for vaginal
approach (Text box 1 case 3), laparotomy after cae-
sarean section to perform B-lynch suture, perforated
appendix, septic abdominal pregnancy and transab-
dominal approach to remove missed miscarriage
in second trimester after failed medical induction.
All five were assessed as having sustained severe
morbidity. Of the unique WHO criteria, ‘bilirubin >
100 mmol/L’ was most frequently present, in 13
women. At the time of study, a hepatitis E outbreak
was ongoing and became the underlying disease in
ten MNM and two maternal deaths.
Figure 2 summarizes the number of units of blood
given to MNM. SSA MNM criterion of at least two
units of blood was fulfilled by 140 women. An esti-
mation of the amount of blood loss was not available
in medical records. Assessment of severity of haemor-
rhage was based on the vitals of the patients and
interventions performed to stop the bleeding. Two
Table 1. Characteristics of all maternal near-miss women.






Para 0 60 30.9%




≤12 weeks 32 16.5%
13–26 weeks 25 12.9%
27–36 weeks 46 23.7%

















Chronic hypertension 3 1.5%
TB 1 0.5%











NVD, normal vaginal delivery; CS, Caesarean section; TOP, termination of
pregnancy; GDM, gestational diabetes mellitus. aNumber of completed
weeks at the end of pregnancy or on admission if undelivered.
Table 2. For each hospital number of live births, maternal
near-miss, maternal deaths, MNM ratio and the SMO ratio.













3515 150 6 43 36–50 44 37–51
Hospital
B
1326 30 3 23 15–31 25 16–33
Hospital
C
664 12a 0 18 8–28 18 8–28
Hospital
D
267 6a 0 22 4–40 22 4–40
Total 5772 194 9 34 29–38 35 30–40
aThree MNM women from hospital C and one MNM woman from
Hospital D were referred to hospital A and part of the total number
of these hospitals. MNM, Maternal Near Miss; MD, Maternal Death; LB,
livebirths; CI, Confidence Interval; SMO, severe maternal outcome.
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Pregnancy with abortive outcome 44 (23%)
















Puerperal sepsis 7 (4%)
Sepsis not puerperal 7 (4%)
Other obstetric complications 3 (1%)





Unanticipated complications of 
management 1 (0%)
Chronic anaemia 5 (3%)
Primary cause MNM
Figure 1. Primary cause of maternal near miss. N = 194. aTwo women with eclampsia also had HELLP syndrome and are
counted twice.
Table 3. Frequencies of maternal near-miss by type of organ system dysfunction.
MNM identification criteria
Total per MNM criterion
N, % (95% CI) MNM by SSA only MNM by WHO only
Severe maternal complications 72, 37.3% (30.3–44.3)
Eclampsia 26 18
Sepsis or severe systemic infection 26 16
Uterine rupture 2 1
Pulmonary oedema 7 2
Severe abortion complications 8 3
Severe malaria 4 0
Severe pre-eclampsia with ICU admission 4 1
Laparotomy other than caesarean section or ectopic pregnancy 12 5
Cardiovascular dysfunction 21, 10.8% (6.8–16.1)
Shock 20
Cardiac arrest 0
Use of continuous vasoactive drugs 3 0
CPR 0
pH < 7.1 1 1
Lactate >5 mEq/mL 0 0
Respiratory function 16, 8.2% (4.8–13.0)
Acute cyanosis 0
Gasping 0
Respiratory rate >40 or <6/min 5
Intubation and ventilation for ≥60 minutes not related to anaesthesia 11
Oxygen saturation <90% for ≥60 minutes 4
Renal dysfunction 4, 2.1% (0.6–5.2)
Oliguria non-responsive to fluids or diuretics 4
Creatinine ≥300 µmol/l or ≥3.5 dL/dL 1
Dialysis for acute renal failure 1 0
Coagulation/hematologic dysfunction 147, 75.8% (69.1–81.6)
Failure to form clots 6
Transfusion of ≥ 2 units of red blood cells 140 103
Acute thrombocytopenia (<50,000 platelets/ml) 12
Hepatic dysfunction 13, 6.7% (3.6–11.2)
Jaundice in the presence of pre-eclampsia 0
Bilirubin >100 mmol/l or >6.0 dL/dL 13 9
Neurological dysfunction 8, 4.1% (1.8–8.0)
Loss of consciousness lasting 12 hours (GCS < 10) 6
Stroke 0
Loss of consciousness and ketoacids in urine 0
Uncontrollable fit 1
New onset of paralysis 1
Uterine dysfunction 6, 3.1% (1.1–6.6)
Hysterectomy following infection or haemorrhage 6
Total 194 133 10
In italics unique SSA criteria and underlined unique WHO criteria. A woman could fulfil more than one MNM criterion. At the top of each section the
total number of women with each organ dysfunction, followed by the proportion, calculated by the total divided by 194 MNM women and presented
as percentage. The second and third column presents the number of women that only fulfilled criteria of either the WHO or SSA set and would have
been missed if the other set was applied. MNM, Maternal near miss; CI, Confidence interval; SSA, sub-Saharan Africa; WHO, World Health organization,
ICU, intensive care unit; CPR, cardiopulmonary resuscitation; GCS, Glasgow coma scale.
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or three units of red cells were given to 95 women for
mild/moderate haemorrhage or chronic anaemia who
did not fulfil any WHO criterion and were not con-
sidered to be MNM. Fourteen women received four
units and were assessed to be MNM from severe
haemorrhage. Even though these women did not
reach the clinical thresholds of shock, they often
had tachycardia and needed several interventions to
stop the bleeding and to restore these clinical para-
meters (Text box 1 case 3 and 4). Of the women
identified through the register of blood bank, 20
women received two units of blood and eight
women three.
If only the WHO criteria would have been applied
to our cohort 61 MNM would have been identified
and if the SSA criteria were applied 184 MNM. In
Textbox 1, several summaries are presented of MNM
that would have been missed if the WHO MNM
criteria were applied.
Long-term outcome
Although 194 women survived the pregnancy-related
complication, 15 (7.7%) women sustained a long-
term complication. Six (3.1%) women underwent
hysterectomy of whom five were haemorrhage and
one infection related. Three (1.5%) women developed
cardiomyopathy and three needed a colostomy: one
woman had iatrogenic bowel perforation during
Text box 1. Summary of cases missed by WHO criteria sorted by assessment of research team as severe or not severe morbidity
case. CS, caesarean section; G, gravida; P, parity; Hb, haemoglobin; WBC, white blood cells x 109/L; RCC, red cell concentrate.
Severe morbidity
Eclampsia
(1) A 17-year old primigravida fitted eight times due to eclampsia at home and in a small district hospital 119 km away from hospital B. She was
referred to hospital B were a CS was done. She recovered well.
Uterine rupture
(2) A 28-year old G3P2 with one previous CS was admitted in active labour in hospital A. An emergency CS was done and a uterine rupture found.
A fresh stillborn baby was delivered. The woman developed a vesicovaginal fistula and received 1 unit of blood during admission.
Laparotomy other than CS or ectopic
(3) A 33-year old G3P2 presented to Hospital A with a septic cervical pregnancy. A hysterotomy, abdominal approach, was done to remove the
pregnancy since a vaginal approach was deemed not to be feasible. To control the bleeding a bilateral ligation of the uterine arteries was done.
The woman did not fulfil the criteria of shock. She received four units of blood and two units fresh frozen plasma.
Transfusion of 2 or more units of blood
(4) A 21-year old primigravida presented to hospital D with severe bleeding due to an incomplete miscarriage. Her Hb was 5.2 g/dL, she received
four units of blood and the retained products of conception were removed.
No severe morbidity
Sepsis
(1) A 27-year old woman developed fever 1 day after her normal delivery in hospital A. She had a heart rate of 100/min, WBC of 9. She was not
acutely ill, endometritis was suspected and she recovered well on intravenous antibiotics.
Transfusion of 2 or more units of blood
(2) A 28-year old G5P4 presented to hospital A with symptomatic anaemia at 32 weeks of gestation. Her Hb was 6.8 g/dL and she was transfused 2
RCCs.
(3 A 17-year old primigravida gave birth in Hospital B with minimal blood loss. During antenatal care an Hb of 5.9 g/dl was found. Three units of








2  R C C 3  R C C 4  R C C ≥  5  R C C
BLOOD TRANSFUSION
Figure 2. Summary of number of women who received two or more units of blood transfusion. In white the women that did not
fulfil another criterion of the WHO set and would have been missed by the WHO MNM criteria. In grey the number of women
that did fulfil another criteria of the WHO MNM criteria. RCC, red cell concentrate.
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caesarean section, one had an abdominal pregnancy
with placental invasion into the sigmoid and one
woman with a previous caesarean section had an
obstructed bowel due to adhesions during her current
pregnancy. Two (1.0%) women had a ruptured uterus
due to obstructed labour of whom one developed
a vesicovaginal fistula. One women with known
chronic renal failure developed acute on chronic
renal failure secondary to pre-eclampsia and was
still in need of dialysis after discharge. The two
women with a uterine rupture, two women who
needed a colostomy and one woman with
a haemorrhage-related hysterectomy had had one or
more previous caesarean sections.
Discussion
In the middle-income setting of Namibia, both the
WHO and SSA MNM criteria cannot be applied
without amendments. Even though the WHO devel-
oped the criteria to be applied across settings, our
findings suggest it would result in an underestimation
of MNM in Namibia, which corresponds with experi-
ences from low-income settings [11,12,16]. The SSA
criteria were proposed for use in low-income settings.
Application of the SSA criteria to our cohort resulted
in an overestimation of MNM which suggests that
both sets are less feasible to be applied to a middle-
income setting such as Namibia. There are several
other middle-income countries which used the
MNM approach. However, they applied the WHO
criteria or locally established criteria without validat-
ing them, and most of these studies only included
referral or tertiary hospitals [16–22]. For example,
a large national study from Brazil included 27 referral
hospitals and used the WHO criteria [18]. India
developed its own MNM criteria and performed
a pilot in six tertiary facilities [22]. A recently pub-
lished systematic review assessed the applicability of
WHO criteria in sub-Saharan Africa and included 15
reports of which four reported findings from middle-
income countries [16,17,23–25]. These four reports
were all from tertiary facilities with availability of
resources to apply the WHO criteria [17,23–25].
For MNM registration in all Namibian hospitals of
all levels, we decided to adopt the WHO criteria with
the addition of the criteria eclampsia, uterine rupture,
laparotomy other than caesarean section or ectopic
pregnancy’ and a lower threshold of four units of
blood. Even though eclampsia and uterine rupture are
not part of theWHO criteria, high case fatality rates are
reported for both conditions across settings [26–28].
Furthermore, these are commonly used in both high-
and low-income countries to define MNM for local and
national registrations and recently suggested as
a standard outcome to define severe morbidity in
maternal health-related research [11,29–32]. To our
knowledge, the criterion ‘Laparotomy other than cae-
sarean section or ectopic pregnancy’ is not commonly
used to define MNM. However, in our cohort, several
women would have been missed and this criterion,
therefore, turned out to be a useful addition. We
opted to change the threshold for blood transfusion to
four units of red cells. The threshold of two or three
units resulted in inclusion of many women with minor
to moderate haemorrhage-related complications, as
well as inclusion of women with chronic anaemia. At
a threshold of five units of blood, women with severe
haemorrhage would have been missed.
The criterion sepsis led to overinclusion in our
cohort of women who were not critically ill. The
SSA set used a definition of sepsis developed for the
non-obstetric population [33]. Amendment of the
definition of sepsis, with higher thresholds of clinical
signs, might lead to better MNM identification. The
remaining SSA criteria (pulmonary oedema, severe
abortion complications, severe malaria and severe
pre-eclampsia with ICU admission), appeared not to
be essential to identify MNM, resulted in inclusion of
women with minor morbidity or were unclear lead-
ing to incorrect inclusion.
The prevalence of SMO is expected to correlate with
the MMR of a country [6]. The WHO multicountry
survey showed an SMO ratio of 15.9/1000 livebirths in
countries with a comparable MMR [15]. By applying
the SSA criteria we found a more than double SMO
ratio, whereas by applying the above-suggested
amendments we would have identified 93 MNM,
which leads to an SMO ratio of 17.5/1000 live births.
We recommend other middle-income countries to
validate our criteria in their setting. A country’s
income level does not necessarily correlate with
maternal outcome [34]. For example, Namibia has
a relatively high prevalence of severe maternal out-
come. The income level is based on national income
per person and does not take into account income
inequities [14]. However, a country’s income level
will, in most cases, affect the availability of resources.
This poses the most important restriction in use of
the WHO MNM criteria.
Access to care does not seem to be a major issue
contributing to poor maternal outcome in Namibia.
The country has one of the best road networks in
Africa and an effective referral system appears to be
in place. This is reflected by the high antenatal care
attendance rate of 96% and the fact that 87% of
women give birth in health facilities, attended by
a skilled health-care worker [9]. A recent national
maternal death review, of which the report is
expected to be published next year, indicates that
most deaths occur whilst the woman is in the health
facility. Namibian health facilities, like most state-
funded facilities in sub-Saharan Africa, have high
turnover of staff, and are staffed mainly by junior
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staff with limited experience and supervision. Within
the five-step ‘obstetric transition’ as described by the
World Health Organization, Namibia is now in stage
III, the typical state of a middle-income country that
has largely overcome barriers for women to access
care, where women are now indeed reaching health
facilities, and hence where improved quality of care
becomes the critical step to achieve a reduction of
maternal mortality [35].
Over 80% of the underlying causes of theMNMwere
direct pregnancy-related causes. We feel that this might
be an overrepresentation, caused by the over-reporting
of haemorrhage. A better representation of the under-
lying causes is expected to be found in the planned
national MNM observational study with the amended
criteria. Abortion-related complications were
the second most common underlying cause of the
MNM. In Namibia, women only have limited access
to abortion and only for significant maternal or fetal
indications. A high incidence of abortion-related MNM
events is seen in other countries where women have
limited access to safe abortion as well [36].
A considerable proportion of our women had
a previous caesarean section and over half of our
women gave birth by caesarean section which corre-
lates with other reports [15]. A possible explanation
for this high proportion could be our sick population.
However, even in an MNM population, there are
reports available indicating a high number of caesar-
ean sections without medical indication and for some
women, the MNM event was the direct result rather
than the indication for caesarean section [37]. In our
cohort, a woman sustained iatrogenic bowel injury
during birth by caesarean section and needed several
laparotomies and went home with a colostomy.
Our study has several limitations. We used
a relatively small cohort and were unable to perform
a sample size calculation. Possibly larger studies, such
as the planned national MNM observational study,
may permit additional conclusions with statistical
significance. Availability of background data was
very limited regarding maternal morbidity and mor-
tality in Namibia. Objective data such as case fatality
rate would have been useful to further support our
decisions to amend the WHO criteria.
Data were collected by local staff who already had
a high workload and MNM might have been missed.
Even though data collection done by full-time
research staff might have been more accurate, we
aimed for data collection mainly done by local staff
as this would enable us to identify barriers and chal-
lenges for a planned routine national MNM data
collection in all Namibian hospitals. The project was
overall well received by staff members as they felt
they could finally report ‘the other side of the story,
rather than only reporting maternal deaths’. The
research team identified an additional 31 women, of
whom the majority appeared to not be critically ill.
This further supports the experience that our staff
were motivated to report MNM. We found a higher
prevalence of MNM in the capital. As the national
referral centre, this was expected. However, this is
most likely also caused by reporting bias since this
was the only facility where data collection was sup-
ported by the research team. We suggest the assess-
ment of long-term complications should become part
of all MNM projects. Even though these women
nearly died but survived a pregnancy-related compli-
cation, a considerable proportion left the hospital
with significant disability.
Conclusions
This report validated MNM criteria to be applied
nationwide in hospitals of all levels in a sub-Saharan
African country. Our findings suggest that a middle-
income country such as Namibia needs MNM criteria
‘in between’ the WHO and SSA criteria. Context-
specific MNM criteria are vital to help Namibia and
other middle-income countries to identify MNM.
Only with accurate MNM criteria can this tool be
used for what it is designed for; to improve maternity
care and to stop women dying of avoidable causes.
We recommend other middle-income countries to
validate our criteria in their setting when the WHO
criteria are not feasible, rather than developing new
criteria, as this will allow comparison of findings.
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Appendices
Appendix 1. Comparison of WHO MNM criteria and SSA MNM criteria.
WHO near-miss criteria Sub-Saharan Africa near-miss criteria
Clinical criteria Clinical criteria
Acute cyanosis Acute cyanosis
Gasping Gasping
Respiratory rate >40 or <6/min Respiratory rate >40 or <6/min
Shocka Shock
Oliguria non-responsive to fluids or diureticsb Oliguria non-responsive to fluids or diuretics
Failure to form clots Failure to form clots
Loss of consciousness lasting >12 h Loss of consciousness lasting 12 hours
Cardiac arrest Cardiac arrest
Stroke Stroke
Uncontrollable fit / total paralysis Uncontrollable fit / total paralysis
Jaundice in the presence of pre-eclampsia Jaundice in the presence of pre-eclampsia
Laboratory-based criteria Laboratory-based criteria
Oxygen saturation <90% for ≥60 minutes Oxygen saturation <90% for ≥60 minutes
PaO2/FiO2 <200 mmHg
Creatinine ≥300µmol/l or ≥3.5mg/dL Creatinine ≥300µmol/l or ≥3.5mg/dL
Bilirubin >100mmol/l or >6.0 mg/dL
pH < 7.1
Lactate >5 mEq/mL
Acute thrombocytopenia (<50,000 platelets/ml) Acute thrombocytopenia (<50,000 platelets/ml)
Loss of consciousness and ketoacids in urine Loss of consciousness and ketoacids in urine
Management-based criteria Management-based criteria
Use of continuous vasoactive drugs
Hysterectomy following infection or haemorrhage Hysterectomy following infection or haemorrhage
Transfusion of ≥5 units of red cells Transfusion of ≥ 2 units of red cells
Intubation and ventilation for ≥60 minutes not related to anaesthesia Intubation and ventilation for ≥60 minutes not related to anaesthesia
Dialysis for acute renal failure
Cardio-pulmonary resuscitation Cardio-pulmonary resuscitation
Laparotomy other than caesarean section or ectopic pregnancy
Severe maternal complications Severe maternal complications
Eclampsia





Severe pre-eclampsia with ICU admission
MNM, Maternal near-miss; SSA, sub-Saharan Africa; WHO, World Health organisation, ICU, intensive care unit; CPR, cardio pulmonary resuscitation; GCS,
Glasgow coma scale. apersistent systolic blood pressure <80 mmHg or a persistent systolic blood pressure <90 mmHg with a pulse rate at least 120
bpm, burinary output <30 ml/hour over 4 hours or <400 ml/24 hr, cpresence of fever (Temp >38°C) AND confirmed or suspected infection AND at least
one of the following: heart rate >90, respiratory rate >20, WBC > 12 or < 4 x 109/L, dcomplete rupture of uterus during labour confirmed by
laparotomy, eseptic incomplete abortion, complicated gestational trophoblastic disease with anaemia, fmajor signs of organ dysfunction and/or high
level parasitaemia or cerebral malaria.
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Appendix 2. Frequencies of maternal near-miss by type of organ system dysfunction in the four hospitals
Facilities
A B C D Total
Severe maternal complications 52 16 4 0 72, 37.3%
Eclampsia 17 7 2 0 26
Sepsis or severe systemic infectionb 22 2 2 0 26
Uterine rupturec 1 1 0 0 2
Pulmonary oedema 5 2 0 0 7
Severe abortion complicationsd 7 1 0 0 8
Severe malariae 0 4 0 0 4
Severe pre-eclampsia with ICU admission 1 3 0 0 4
Laparotomy other than caesarean section or ectopic pregnancy 12 0 0 0 12
Cardiovascular dysfunction 17 2 2 0 21, 10.8%
Shockf 16 2 2 0 20
Cardiac arrest 0 0 0 0 0
Use of continuous vasoactive drugs 3 0 0 0 3
CPR 0 0 0 0 0
pH < 7.1 1 0 0 0 1
Lactate >5 mEq/mL 0 0 0 0 0
Respiratory function 14 2 0 0 16, 8.3%
Acute cyanosis 0 0 0 0 0
Gasping 0 0 0 0 0
Respiratory rate >40 or <6/min 4 1 0 0 5
Intubation and ventilation for ≥60 minutes not related to anaesthesia 10 1 0 0 11
Oxygen saturation <90% for ≥60 minutes 4 0 0 0 4
Renal dysfunction 3 1 0 0 4, 2.0%
Oliguria non-responsive to fluids or diureticsg 3 1 0 0 4
Creatinine ≥300µmol/l or ≥3.5mg/dL 1 0 0 0 1
Dialysis for acute renal failure 1 0 0 0 1
Coagulation/hematologic dysfunction 112 24 6 5 147, 75.8%
Failure to form clots 4 2 0 0 6
Transfusion of ≥ 2 units of red blood cells 108 21 6 5 140
Acute thrombocytopenia (<50,000 platelets/ml) 8 4 0 0 12
Hepatic dysfunction 12 1 0 0 13, 6.7%
Jaundice in the presence of pre-eclampsia 0 0 0 0 0
Bilirubin >100mmol/l or >6.0 mg/dL 12 1 0 0 13
Neurological dysfunction 6 2 0 0 8, 4.2%
Loss of consciousness lasting 12 hours (GCS < 10) 4 2 0 0 6
Stroke 0 0 0 0 0
Loss of consciousness and ketoacids in urine 0 0 0 0 0
Uncontrollable fit 1 0 0 0 1
New onset of paralysis 1 0 0 0 1
Uterine dysfunction 5 1 0 0 6, 3.0%
Hysterectomy following infection or haemorrhage 5 1 0 0 6
Total 150 30 9 5 194
Italics unique SSA criteria and underlined unique WHO criteria. A woman could fulfil more than one MNM criterion. At the top of each section the total
number of women with each organ dysfunction, followed by the proportion, calculated by this total divided by 194 MNM women and presented as
percentage. MNM, Maternal near miss; SSA, sub-Saharan Africa; WHO, World Health organisation, ICU, intensive care unit; CPR, cardio pulmonary
resuscitation; GCS, Glasgow coma scale.
bpresence of fever (Temp >38°C) AND confirmed or suspected infection AND at least one of the following: heart rate >90, respiratory rate >20, WBC > 12
or < 4 x 109/L; ccomplete rupture of uterus during labour confirmed by laparotomy; dseptic incomplete abortion, complicated gestational trophoblastic
disease with anaemia; emajor signs of organ dysfunction and/or high level parasitaemia or cerebral malaria; fpersistent systolic blood pressure <80
mmHg or a persistent systolic blood pressure <90 mmHg with a pulse rate at least 120 bpm; gurinary output <30 ml/hour over 4 hours or <400 ml/24
hr.
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